Company Overview and News


Add 4151
to your dashboard

Headline News

ArQule's (ARQL) CEO Paolo Pucci on Q3 2017 Results - Earnings Call Transcript

2017-11-09 seekingalpha
Good day, ladies and gentlemen and welcome to the ArQule Third Quarter 2017 Earnings Conference Call. At this time all participants are in a listen-only mode. Later there will be a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder this conference call is being recorded. (11-1)

Syndax Pharmaceuticals' (SNDX) CEO Briggs Morrison on Q3 2017 Results - Earnings Call Transcript

2017-11-08 seekingalpha
Good day, ladies and gentlemen, and welcome to the Syndax Third Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will begin at that time. [Operator Instructions]. As a reminder, this conference call maybe recorded. (5-0)

Japan's Kirin cashes out of Amgen drug joint venture - Channel NewsAsia

2017-10-31 channelnewsasia
TOKYO: Japan's Kirin Holdings Co Ltd said on Tuesday it would sell its share in a pharmaceutical research joint venture with California-based drugmaker Amgen Inc for US$780 million. (67-0)

Japan's Kirin cashes out of Amgen drug joint venture

2017-10-31 reuters
TOKYO (Reuters) - Japan’s Kirin Holdings Co Ltd (2503.T) said on Tuesday it would sell its share in a pharmaceutical research joint venture with California-based drugmaker Amgen Inc (AMGN.O) for $780 million. (67-0)

Nikkei tops 22,000 for first time in over 21 years

2017-10-28 japantimes.co.jp
The benchmark Nikkei average surged on the Tokyo Stock Exchange Friday on the strength of brisk corporate earnings, surpassing the 22,000 threshold for the first time in almost 21 years and four months.